Abstract
Abstract A number of decamethylenebis[4-(substituted amino)quinaldinium acetates] have been prepared and certain of these showed markedly increased antibacterial activity compared with the unsubstituted compound. Local therapeutic activity, assessed by mouse protection tests, reached a maximum in the C3–C6 range of the n-alkylamino-homologues, but increased activity was associated with increased toxicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
